Tag: EVE
THC Global and Eve Investments to advance medicinal cannabis partnership following manufacturing licence
In the wake of THC Global (ASX: THC) reporting it has secured its medicinal cannabis manufacturing licence, partner Eve Investments (ASX: EVE) noted the licence now paves the way for the duo to advanc...
EVE Investments strikes deal with OpenDNA to sweeten Meluka Honey impact in China
Health and nutrition investment company EVE Investments (ASX: EVE) has struck a timely deal with OpenDNA (ASX: OPN) in a bid to improve its marketing and sales support for its range of honey products ...
EVE Investments snaps up organic medicinal honey firm Meluka Health
EVE Investments (ASX: EVE) has shored up future revenue growth after announcing plans to acquire full ownership of wellness company Meluka Health.
EVE Investments said it had entered into a share p...
EVE Investments and Meluka Honey prepare products with anti‐microbial and anti‐oxidant effects
Health and nutrition investment company EVE Investments (ASX: EVE) has announced key findings from recent research trials into Melaleuca trees – the source of many of its products aimed at Australian ...
EVE Investments acquires leading Australian organic tea tree oil producer
EVE Investments (ASX: EVE) emerged out its trading halt earlier today to announce that it intends to acquire the entirety of organic tea tree oil producer Jenbrook for around A$2.9 million from its fo...
The Hydroponics Company looks to seize tea tree extract commercial opportunity
Medicinal cannabis developer The Hydroponics Company (ASX: THC) is aiming to add significant production capabilities to its recently-acquired growing facility, and thereby continue the build-up of its...
Eagle Health tackles China’s diabetes problem
Nutritional products distributor Eagle Health Holdings (ASX: EHH) launched its clinically-tested ‘Hutang 1’ product to combat Type 2 diabetes and blood glucoses imbalances late last year and has updat...
Eagle Health launches diabetic product into China, EVE Investments part-owner
Eagle Health Holdings (ASX: EHH) has launched its Omni Innovation’s diabetes pre-meal shake into China’s Xiamen city as part of its plan to roll the product out across the country.
In September, Ea...
EVE secures stake in Meluka Health, kicks-off honey water development for China market
Darling of the small cap ‘pot stocks’ EVE Investments (ASX: EVE) has cemented its 50% stake in Meluka Health, which announced this morning it plans to develop honey water for the Chinese market.
Me...
EVE Investments’ subsidiary Meluka Health locks-in research grant
EVE Investments (ASX: EVE) reported its 50%-owned Meluka Health has received a New South Wales TechVoucher grant worth up to A$15,000 to support its bee health and honey research.
Via the TechVouch...
EVE Investments JV produces Australia’s first hemp seed honey
EVE Investments (ASX: EVE) today announced the subsidiary of its joint venture company Meluka Health has produced Australia’s first 100% organic hemp seed honey.
Meluka’s wholly owned subsidiary Me...
EVE Investments appoints leading medicinal cannabis advisor
EVE Investments's (ASX: EVE) newly formed venture company, Medic Honey Pty Ltd, has appointed leading Australian medicinal cannabis advisor BuddingTech Pty Ltd as advisor to the board.
Key Highligh...
